Why do Neuro Drug Trials/ Studies Fail?
Neurologic evaluations remain highly subjective in a time of transformative digital advances. The big unmet need for the neurosciences is a practical tool that provides highly sensitive, objective neuro-functional data. Given the poor track record of FDA approvals for neuro-drugs, one would think the drug companies would be at the front of the line to fund such advances. The reality, however, is that companies with or close to a solution are starving for capital.
As before, feel free to head to my website https://rzacquisition.com/ where both Post #1 & 2 of the, "Neurosciences –Need is Growing, but not Investments", can be found. Post #3 will be next week.
Thank you for your interest and please feel free to comment.
J Howison Schroeder